Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs LII✓SelectedUSD · LIIGSK vs LII performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs LII

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+107.9%
LII return
+149.6%
Excess return
-41.7%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioLIIExcessAlpha
1D-0.1%-4.7%+4.7%+0.7%
7D-1.3%-4.0%+2.7%-0.6%
30D+2.7%-6.3%+9.0%+3.8%
3M+2.7%-20.2%+22.9%+6.5%
6M+3.3%-32.5%+35.8%+9.2%
YTD+6.5%-30.3%+36.8%+11.5%
1Y+10.7%-28.0%+38.7%+15.2%
3Y+64.4%-14.8%+79.1%+61.7%
5Y+46.7%+10.8%+35.9%+34.4%
All+107.9%+149.6%-41.7%+60.3%

Cumulative growth

Daily Returns

Daily percentage return beside LII.

Daily Out/Under-Performance

Portfolio return minus LII return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LII return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded LII wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling